Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study

Catégorie Primary study
JournalJ Clin Oncol
Year 2008

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: db479791fcd69a92477907aa77394897273faa7c
First added on: Oct 05, 2017